The molecular form of α2-antiplasmin with affinity for plasminogen is selectively bound to fibrin by factor XIII
- 1 February 1984
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 33 (4) , 419-425
- https://doi.org/10.1016/0049-3848(84)90081-1
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Factor XIII‐mediated cross‐linking of NH2‐terminal peptide of α2‐plasmin inhibitor to fibrinFEBS Letters, 1983
- A bleeding disorder due to deficiency of alpha 2-antiplasminBlood, 1982
- A familial hemorrhagic diathesis in a Dutch family: an inherited deficiency of alpha 2-antiplasminBlood, 1982
- Cross-linking of α2-plasmin inhibitor and fibronectin to fibrin by fibrin-stabilizing factorBiochimica et Biophysica Acta (BBA) - Enzymology, 1981
- Demonstration of two forms of α2-antiplasmin in plasma by modified crossed immunoelectrophoresisThrombosis Research, 1981
- Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor.Journal of Clinical Investigation, 1980
- On the specific interaction between the lysine-binding sites in plasmin and complementary sites in α2-antiplasmin and in fibrinogenBiochimica et Biophysica Acta (BBA) - Protein Structure, 1979
- Congenital Deficiency of α2-Plasmin Inhibitor Associated with Severe Hemorrhagic Tendency *Journal of Clinical Investigation, 1979
- Fast-acting plasmin inhibitor in human plasmaBlood, 1978
- Plasminogen: Purification from Human Plasma by Affinity ChromatographyScience, 1970